+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Apellis Pharmaceuticals - logo

Apellis Pharmaceutical was founded in 2009 in Crestwood, U.S.A. It is a company with the aim of innovating and creating products to treat autoimmune and inflammatory diseases. Our lead compounds are designed to broadly inhibit complement C3, which is the central protein in the complement system.The complement system plays a key role in a wide range of autoimmune and inflammatory diseases. They believe with the use of C3 inhibition it may correct the immunological dysfunction. The approach they apply to this process is known as complement immunotherapy.

Autoimmune Hemolytic Anemia Therapeutics Market 2024-2028 - Product Thumbnail Image

Autoimmune Hemolytic Anemia Therapeutics Market 2024-2028

  • Report
  • June 2024
  • 145 Pages
  • Global
From
From
From
From
From
From
From
Paroxysmal Nocturnal Haemoglobinuria - Pipeline Insight, 2024 - Product Thumbnail Image

Paroxysmal Nocturnal Haemoglobinuria - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Cold Agglutinin Disease Market Report and Forecast 2023-2031 - Product Thumbnail Image

Cold Agglutinin Disease Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
From
From
Collaboration Deals in Pharmaceuticals 2019-2024 - Product Thumbnail Image

Collaboration Deals in Pharmaceuticals 2019-2024

  • Report
  • September 2024
  • 1150 Pages
  • Global
From
Licensing Deals in Pharmaceuticals 2019-2024 - Product Thumbnail Image

Licensing Deals in Pharmaceuticals 2019-2024

  • Report
  • September 2024
  • 1400 Pages
  • Global
From
Loading Indicator